Balance and Resistance Activities for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether an 8-week digital health program called COBRA, which promotes physical activity and overall well-being, is a safe and practical option for older adults with cancer. It focuses on patients who have recently completed their main cancer treatment or have stable metastatic cancer. The trial aims to determine if participants can benefit from increased physical activity and overall well-being. Individuals aged 65 and older, who speak English and have internet access, may be suitable if they have completed primary cancer therapy or have a stable cancer diagnosis. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative research aimed at enhancing the quality of life for older adults with cancer.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the COBRA program is safe for older adults with cancer?
Research has shown that exercise programs can be safe and beneficial for cancer patients. Specifically, studies on prehabilitation, or exercising before treatment, have indicated better patient outcomes. The COBRA program is an 8-week online health initiative designed for older adults with cancer.
While specific side effects from COBRA are not detailed, similar programs have been well-tolerated. Exercise programs like COBRA generally pose low risk and aim to improve balance and strength. The trial is in the "not applicable" phase, meaning it is being tested for feasibility and safety, not as a new drug treatment. This suggests that serious side effects are unlikely.
Overall, the program seeks to help older adults with cancer engage in healthy activities, which is typically safe and practical.12345Why are researchers excited about this trial?
The COBRA treatment is unique because it focuses on balance and resistance activities specifically designed for older adults who have completed cancer therapy or have metastatic cancer. Unlike standard cancer rehabilitation programs that might not tailor activities by age or physical condition, COBRA offers a customized approach that considers the unique needs and limitations of older cancer patients. Researchers are excited about this trial because it could improve not only physical strength and balance but also overall quality of life, potentially reducing the risk of falls and enhancing recovery in a way that standard treatments do not.
What evidence suggests that the COBRA program is effective for older adults with cancer?
Research shows that activities focused on balance and strength can help older adults with cancer improve their physical abilities. Studies have found that 71% of cancer rehabilitation programs report noticeable improvements in participants' functional abilities. This often leads to better strength, balance, and overall physical health. In this trial, the COBRA program is being tested as a digital tool designed to be safe and easy to use for older adults. Early results suggest it may help maintain or improve physical abilities in this group.12367
Who Is on the Research Team?
Kristen Fessele, PhD, RN
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
The COBRA trial is for older adults who have been diagnosed with cancer. Specific details about eligibility criteria are not provided, but typically participants would need to be able to engage in balance and resistance activities.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week digital health promotion program called COBRA
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- COBRA
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor